Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial tags : Events save search
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Published: 2024-04-19 (Crawled : 22:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
infection antibiotics trials for
Kiora Pharmaceuticals to Present Additional Data from Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting
Published: 2024-03-28 (Crawled : 16:00) - biospace.com/
KPRX | $0.502 -1.57% -1.59% 49K
|
Manufacturing
|
| O: -2.26%
H: 20.0%
C: 17.67%
pharmaceuticals meeting trial
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
GKOS | $96.5 1.44% 0.0% 700K
|
Health Technology
|
| O: 0.73%
H: 2.38%
C: 0.0%
innovation vision technology
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
Published: 2024-03-20 (Crawled : 19:00) - biospace.com/
LIVN | $52.31 -0.85% -0.86% 430K
|
Health Technology
|
| O: 1.81%
H: 11.57%
C: 10.5%
success positive trial study
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Published: 2024-03-05 (Crawled : 12:30) - biospace.com/
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 1.89%
H: 0.02%
C: -4.13%
omnipod first conference international trial advanced diabetes results
Evolus Announces Results from European Head-to-Head Filler Trial
Published: 2024-03-01 (Crawled : 14:30) - biospace.com/
EOLS | $11.49 -0.61% -0.61% 350K
|
Health Technology
|
| O: 0.0%
H: 1.69%
C: 0.54%
trial results
Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 0.71%
H: 4.26%
C: 3.9%
trials
Actinium Announces Iomab-B Markedly Increases Long Term Survival in Patients 65 Years or Older with Active Relapsed or Refractory AML in the Phase 3 SIERRA Trial
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
ATNM | $6.85 2.7% 0.0% 350K
|
Health Technology
|
| O: 2.04%
H: 19.98%
C: 18.71%
active aml trial
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024
Published: 2024-02-20 (Crawled : 14:00) - biospace.com/
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 2.59%
H: 15.53%
C: 7.18%
enous2024 topline meeting medical trial
Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Phase 2 Clinical Trial of ADX-629 in Patients with Atopic Dermatitis
Published: 2023-12-18 (Crawled : 23:00) - biospace.com/
ALDX | $3.865 -2.89% -2.98% 430K
|
Health Technology
|
| O: 1.32%
H: 3.27%
C: -3.27%
adx-629 conference dermatitis trial therapeutics results
City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -0.07%
H: 1.35%
C: -0.1%
conference hope city trial potential therapy
Science 37 Receives Top Honors in Everest PEAK Matrix®Science 37 emerges as the only clinical trial site to be recognized as a Leader in Decentralized Clinical Trials
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
SNCE | $5.75 0.26% 49K
|
|
| O: -3.64%
H: 7.57%
C: 4.26%
matrix trials trial
Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition
Published: 2023-12-12 (Crawled : 07:00) - biospace.com/
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 1.04%
H: 0.5%
C: -0.63%
positive trials meeting results
Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
Published: 2023-11-13 (Crawled : 14:30) - biospace.com/
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.02%
H: 4.5%
C: 3.38%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.04%
H: 1.92%
C: 1.89%
meeting hepatitis liver ongoing trials today
MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 Phase 2 Clinical Trial at European Society for Medical Oncology Congress 2023
Published: 2023-10-19 (Crawled : 14:00) - biospace.com/
MAIA | $2.15 9.69% 0.0% 100K
|
|
| O: -0.87%
H: 7.89%
C: 3.07%
thio-101 congress medical trial
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in OctoberPresentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy
Published: 2023-10-06 (Crawled : 13:00) - biospace.com/
OCUP | $1.66 -0.6% -0.6% 230K
|
Health Technology
|
| O: -0.29%
H: 2.62%
C: 2.62%
apx3330 pharma retina trial diabetic
Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials
Published: 2023-08-30 (Crawled : 14:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.24%
H: 0.87%
C: -0.12%
institute test cancer trials sciences
Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 2 Clinical Trial of ADX-2191 in Patients with Retinitis Pigmentosa
Published: 2023-06-28 (Crawled : 22:00) - biospace.com/
ALDX | $3.865 -2.89% -2.98% 430K
|
Health Technology
|
| O: -0.67%
H: 6.07%
C: 4.32%
adx-2191 conference trial therapeutics results
ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress
Published: 2023-06-09 (Crawled : 09:00) - biospace.com/
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.4%
H: 4.46%
C: 3.37%
cell trial
Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress
Published: 2023-06-09 (Crawled : 09:00) - biospace.com/
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.28%
H: 0.44%
C: 0.18%
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: 8.5%
H: 0.52%
C: -9.82%
disease association positive cell trials results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.